Description: BioLife Solutions, Inc. (BioLife) is engaged in the developing, manufacturing and marketing hypothermic storage and cryopreservation solutions for cells and tissue. The Company’s product offerings include biopreservation media products for cells, tissues, and organs; generic formulations of blood stem cell freezing media products; custom product formulation and custom packaging services; precision thermal packaging products and C=contract aseptic manufacturing formulation, fill, and finish services of liquid media products. The Company markets it’s HypoThermosol, CryoStor, generic BloodStor, SAVSU biopreservation media products and precision thermal packaging products to the biobanking, drug discovery, and regenerative medicine markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, hair transplant centers, and suppliers of cells to the drug discovery, toxicology testing and diagnostic markets.
Home Page: www.biolifesolutions.com
BLFS Technical Analysis
3303 Monte Villa Parkway
Bothell,
WA
98021
United States
Phone:
425 402 1400
Officers
| Name | Title |
|---|---|
| Mr. Michael P. Rice | Chairman & CEO |
| Mr. Roderick de Greef | Pres & COO |
| Mr. Troy Wichterman | Chief Financial Officer |
| Dr. Aby J. Mathew | Chairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer |
| Mr. Marcus Schulz | Chief Revenue Officer |
| Mr. Todd Berard | Chief Marketing Officer |
| Ms. Sarah Aebersold J.D. | VP of Global HR |
| Ms. Karen Foster | Chief Quality Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Supplies |
| Forward PE: | 625 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.0333 |
| Price-to-Sales TTM: | 4.9132 |
| IPO Date: | 1989-11-22 |
| Fiscal Year End: | December |
| Full Time Employees: | 432 |